Scientific Program

08:30 – 08:45Welcome and Opening Ceremony Jesús Lafuente, David Rodríguez, Magdy Selim
09:00 – 11:00Special session Management Chronic Subdural Hematoma
12:00 – 17:00HEADS
16:00 – 20:00Ismins
08:30 – 08:45OPENING CEREMONY AND WELCOME TO COUNTRY
Chairs: Craig Anderson & Magdy Selim
08:45 – 10:30SESSION I – WHERE NEXT FOR MEDICAL TREATMENT?
Chairs: David Rodríguez, Chao You
08:45 – 09:10Haemostatic therapy, Nikola Sprigg
09:10 – 09:30Blood pressure lowering treatment, Xia Wang, Lili Song
09:30 – 09:45Expert discussants, Kazunori Toyoda, Timothy Kleinig, Adnan Qureshi
09:45 – 10:00Audience discussion
10:00 – 10:30Oral Presentations
Optimal Magnitude of Blood Pressure Reduction and Hematoma Growth and Functional Outcomes in ICH, Qi Li
Stable SBP Reduction as a Therapeutic Goal in ICH: Pooled Analysis of ATACH-2 and INTERACT-2 Trials, Adnan I. Qureshi
Remote Ischemic Conditioning for Patients With Supratentorial Intracerebral Hemorrhage (RICH-2), Wenbo Zhao
10:30 – 11:00Morning break
11:00 – 12:20SESSION II – BASIC SCIENCE, PATHOPHYSIOLOGY, NOVEL THERAPIES
Chairs: Richard Keep, Adrian Parry-Jones
11:00 – 11:20Expert Overview, Richard Keep
11:20 – 11:40Expert discussant, Adrian Parry-Jones, Nikola Sprigg
11:40 – 12:00Audience discussion
12:00 – 12:20Oral Presentations
Desmopressin for reversal of Antiplatelet drugs in Stroke due to intracerebral Haemorrhage (DASH-2), Nikola Sprigg
Complement cascade shapes early inflammatory and phagocytic homeostasis in intracerebral hemorrhage, Fan Xia
12:20 – 13:30Lunch
12:45 – 13:30POSTER SESSION I
13:30 – 15:00SESSION III – EAST MEETS WEST FOR SURGICAL TREATMENT
Chairs: Xunming Ji, Gao Chen
13:30 – 13:45Minimally invasive surgery in China, Zhenchun Liu, Xia Wang
13:45 – 14:00Minimally invasive surgery outside China, Karin Klijn

14:00 – 14:10

Minimally invasive surgery in Australia, Amal Abou-Hamden

14:10 – 14:20

RAINBOW-ICH: a multicentre, RAndomIsed, coNtrolled, umBrella trial fOr minimally invasive neurosurgery With AI-assisted robotic guIdanCe for Haemorrhagic stroke, Xiaobo Yu
14:20 – 14:30Discussion
14:30 – 15:00Oral Presentations
Association Between Hematoma Evacuation and Ischemic Events: A MISTIE III and ATACH-2 Analysis, Wendy Ziai
Minimally Invasive Surgery for Deep and Lobar Intracranial Hemorrhages: 180-day MIND study results, Christopher Kellner
Comparison of Minimally Invasive Surgery Treatments for Hypertension Intracerebral Hemorrhage, Yuanwei Li
15:00 – 15:30Afternoon break
15:30 – 17:00SESSION V – DIRECTIONS FOR PRE-HOSPITAL MANAGEMENT
Chairs: Thorsten Steiner, Carlos Molina
15:30 – 15:45GFAP and clinical prediction, Cheryl Carcel
15:45 – 16:00Novel imaging and devices,Geoffrey Donnan
16:00 – 16:15Ambulance pathways and management, David Paterson
16:15 – 16:30Discussion
16:30 – 17:00Oral Presentations
Pre-hospital blood pressure variability in intracerebral hemorrhage on a Mobile Stroke Unit, Chloe Mutimer
Impact of Direct Transfer of ICH to the Angiosuite on BP and Anticoagulation Reversal Time Metrics, David Rodriguez-Luna
17:00Finish
18:30 – 21:30WELCOME RECEPTION
10:30 – 11:00Morning break
12:30 – 13:30Lunch
12:45 – 13:30POSTER SESSION I
13:30 – 15:00

SESSION IV – ISSUES OF REHABILITATION AND RECOVERY

Chairs: Sylaja PN, Michael Pollack

13:30 – 13:45Early mobilisation, Emily Ramage
13:45 – 14:00Cognition and dementia, Hsin-Hsi (Cynthia) Tsai
14:00 – 14:10Management of complications, Michael Pollack
14:10 – 14:30Discussion
14:30 – 15:00Oral Presentations
Intracerebral hemorrhage intelligent staging based on a symptom-time extracted large language model, Xiaochao Luo
Quality of Functional Outcome and its determinants in ICH. Insights from the INTERACT3 trial, Carlos Delfino
15:00 – 15:30Afternoon break
15:30 – 17:00

SESSION VI – TRENDS IN EPIDEMIOLOGY AND OUTCOMES

Chairs: Octavio Pontes Neto, Sylaja PN

15:30 – 15:45Burden of disease – Vasileios-Arsenois Lioutas
15:45 – 16:00Recovery patterns – Octavio Pontes Neto
16:00 – 16:15Management in low-resource settings – Sylaja PN
16:15 – 16:30Discussion
16:30 – 17:00Oral Presentations
Burden of Stroke and Risk Factors in China: an Analysis of the Global Burden of Disease Study 2021, Siyu Yan
Impact of socioeconomic status on functional outcome after stroke in Ulaanbaatar, Mongolia, Yijie Gao
17:00Finish
18:30 – 21:30WELCOME RECEPTION
08:30 – 08:45 Welcome and Opening Ceremony Jesús Lafuente, David Rodríguez, Magdy Selim
08:45 – 10:15 Improving ICH Systems of Care
10:15 – 10:45 Coffee Break
10:45 – 12:15 Emergency Management
12:15 – 13:45 Lunch
13:30 – 15:15 Cocktail I
15:15 – 15:30 Coffee Break
15:30 – 17:00 Surgical Treatment (I)
18:00 – 19:30 Welcome Reception
08:30 – 8:45:00WICH Executive Board meeting – (Meeting Room: Pendlebury)
(per invitation only)
10:00 – 10:30Morning break
10:30 – 12:00Advancing Clinical Trials
(per invitation only)
Chairs: Craig Anderson & Magdy Selim
INTERACT5, Lili Song & Xin (Eric) Hu
International cooperation and funding – ACT Global, Xiaoying Chen
StrokeNet perspectives, Magdy Selim
Prospective meta-analysis and data sharing, Xia Wang, Niki Sprigg
Registries, David Seiffge
12:00 – 13:00Lunch
13:00 – 15:15HEADS Meeting EVERY MINUTE COUNTS: A PARADIGM SHIFT IN ICH
(per invitation only)
Session I
Welcome / introductions
Chairs: Chao You, Kazunori Toyoda
Detection of ICH in the field (GFAP and imaging), Love-Preet Kalra, Geoffrey Donnan, Stuart Crozier 
Approaches to surgical evacuation, Jay Mocco, Amal Abou-Hamden, Xing (Eric) Hu, Andrew Mould
Reversal of coagulopathy, Geoffrey Donnan, David Seiffge
15:15 – 15:30Afternoon break
15:30 – 17:00HEADS Meeting EVERY MINUTE COUNTS: A PARADIGM SHIFT IN ICH
(per invitation only)
Session II
Chairs: Karin Klijn, Xin Chen
Approaches to BP lowering, Lili Song, Craig Anderson
Reorganizing ICH systems of care and use of AI, Teresa Ullberg, Carlos Molina
17:00 – 18:30Break
19:00HEADS DINNER
(per invitation only)
08:30 – 10:00Advancing clinical trials on the surgical management of ICH
10:00 – 10:30Coffee Break
10:30 – 11:00WICH General Ass
The Hoff Award
11:00 – 12:30Cocktail I
12:30 – 13:30Lunch
13:30 – 15:30Surgical Treatment II Germinal Matrix Hemorrhage and Intraventricular Therapies
15:30 – 16:00Coffee Break
16:00 – 17:15Prevention & Challenging Decision-Making
17:15 – 17:30Closing Ceremony and Group Photo
18:00Guided tour Sagrada Familia
20:30Gala dinner Hospital de Sant Pau
08:30 – 08:45OPENING CEREMONY AND WELCOME TO COUNTRY
Chairs: Craig Anderson & Magdy Selim
08:45 – 10:30SESSION I – WHERE NEXT FOR MEDICAL TREATMENT?
Chairs: David Rodríguez, Chao You
08:45 – 09:10Haemostatic therapy, Nikola Sprigg
09:10 – 09:30Blood pressure lowering treatment, Xia Wang, Lili Song
09:30 – 09:45Expert discussants, Kazunori Toyoda, Timothy Kleinig, Adnan Qureshi
09:45 – 10:00Audience discussion
10:00 – 10:30Oral Presentations
Optimal Magnitude of Blood Pressure Reduction and Hematoma Growth and Functional Outcomes in ICH, Qi Li
Stable SBP Reduction as a Therapeutic Goal in ICH: Pooled Analysis of ATACH-2 and INTERACT-2 Trials, Adnan I. Qureshi
Remote Ischemic Conditioning for Patients With Supratentorial Intracerebral Hemorrhage (RICH-2), Wenbo Zhao
10:30 – 11:00Morning break
11:00 – 12:20SESSION II – BASIC SCIENCE, PATHOPHYSIOLOGY, NOVEL THERAPIES
Chairs: Richard Keep, Adrian Parry-Jones
11:00 – 11:20Expert Overview, Richard Keep
11:20 – 11:40Expert discussant, Adrian Parry-Jones, Nikola Sprigg
11:40 – 12:00Audience discussion
12:00 – 12:20Oral Presentations
Desmopressin for reversal of Antiplatelet drugs in Stroke due to intracerebral Haemorrhage (DASH-2), Nikola Sprigg
Complement cascade shapes early inflammatory and phagocytic homeostasis in intracerebral hemorrhage, Fan Xia
12:20 – 13:30Lunch
12:45 – 13:30POSTER SESSION I
13:30 – 15:00SESSION III – EAST MEETS WEST FOR SURGICAL TREATMENT
Chairs: Xunming Ji, Gao Chen
13:30 – 13:45Minimally invasive surgery in China, Zhenchun Liu, Xia Wang
13:45 – 14:00Minimally invasive surgery outside China, Karin Klijn

14:00 – 14:10

Minimally invasive surgery in Australia, Amal Abou-Hamden

14:10 – 14:20

RAINBOW-ICH: a multicentre, RAndomIsed, coNtrolled, umBrella trial fOr minimally invasive neurosurgery With AI-assisted robotic guIdanCe for Haemorrhagic stroke, Xiaobo Yu
14:20 – 14:30Discussion
14:30 – 15:00Oral Presentations
Association Between Hematoma Evacuation and Ischemic Events: A MISTIE III and ATACH-2 Analysis, Wendy Ziai
Minimally Invasive Surgery for Deep and Lobar Intracranial Hemorrhages: 180-day MIND study results, Christopher Kellner
Comparison of Minimally Invasive Surgery Treatments for Hypertension Intracerebral Hemorrhage, Yuanwei Li
15:00 – 15:30Afternoon break
15:30 – 17:00SESSION V – DIRECTIONS FOR PRE-HOSPITAL MANAGEMENT
Chairs: Thorsten Steiner, Carlos Molina
15:30 – 15:45GFAP and clinical prediction, Cheryl Carcel
15:45 – 16:00Novel imaging and devices,Geoffrey Donnan
16:00 – 16:15Ambulance pathways and management, David Paterson
16:15 – 16:30Discussion
16:30 – 17:00Oral Presentations
Pre-hospital blood pressure variability in intracerebral hemorrhage on a Mobile Stroke Unit, Chloe Mutimer
Impact of Direct Transfer of ICH to the Angiosuite on BP and Anticoagulation Reversal Time Metrics, David Rodriguez-Luna
17:00Finish
18:30 – 21:30WELCOME RECEPTION
10:30 – 11:00Morning break
12:30 – 13:30Lunch
12:45 – 13:30POSTER SESSION I
13:30 – 15:00

SESSION IV – ISSUES OF REHABILITATION AND RECOVERY

Chairs: Sylaja PN, Michael Pollack

13:30 – 13:45Early mobilisation, Emily Ramage
13:45 – 14:00Cognition and dementia, Hsin-Hsi (Cynthia) Tsai
14:00 – 14:10Management of complications, Michael Pollack
14:10 – 14:30Discussion
14:30 – 15:00Oral Presentations
Intracerebral hemorrhage intelligent staging based on a symptom-time extracted large language model, Xiaochao Luo
Quality of Functional Outcome and its determinants in ICH. Insights from the INTERACT3 trial, Carlos Delfino
15:00 – 15:30Afternoon break
15:30 – 17:00

SESSION VI – TRENDS IN EPIDEMIOLOGY AND OUTCOMES

Chairs: Octavio Pontes Neto, Sylaja PN

15:30 – 15:45Burden of disease – Vasileios-Arsenois Lioutas
15:45 – 16:00Recovery patterns – Octavio Pontes Neto
16:00 – 16:15Management in low-resource settings – Sylaja PN
16:15 – 16:30Discussion
16:30 – 17:00Oral Presentations
Burden of Stroke and Risk Factors in China: an Analysis of the Global Burden of Disease Study 2021, Siyu Yan
Impact of socioeconomic status on functional outcome after stroke in Ulaanbaatar, Mongolia, Yijie Gao
17:00Finish
18:30 – 21:30WELCOME RECEPTION

 

08:45

WelcomeJesús Lafuente & Ramon Torné 

09:00 – 10:30

15 min each

Special session Management Chronic Subdural Hematoma

Moderators: J. Lafuente y Ramon Navarro

  • 09:00 – 09:15 Mechanisms and Pathophysiology of Chronic Subdural Hematoma – Alejandra Mosteiro

  • 09:15 – 09:30 Current Evidence Landscape: Literature Review and Ongoing Clinical Trials – Nikolay Velinov

  • 09:30 – 09:45 Clinical Decision-Making: Indications and Patient Selection for Treatment – Ramon Torné

  • 09:45 – 10:00 MMA Anatomy, Collateral Networks, and Endovascular Access Strategies – Mariano Wegner

  • 10:00 – 10:15 State-of-the-Art Techniques and Devices for MMA Embolization – Simone Peschillo

  • 10:15 – 10.30 Hybrid Management Strategies for Chronic Subdural Hematoma – Jeroen Boogaarts

 

10:30 – 11:00

Coffee Break

11:00 – 12:00

15 min each

Special session Management Chronic Subdural Hematoma

Moderators: J. Lafuente y Ramon Navarro

  • 11:00 – 11.15 Avoiding and Managing Complications in MMA Embolization – Luis Sanroman

  • 11:15 – 11.30 Implementing an MMA Embolization Program: Clinical Pathways and Workflow Integration – Jordi Blasco

  • 11:30 – 11.45 Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH) – Jiri Bartek

  • 11:45 – 12.00 Oral Discussion

12:00 – 12:45

HEADS – Surgery in ICH:  Challenges, Opportunities and Future Frontiers Program (By Invitation Only)

OPENING SESSION – INTRODUCTION

  • 12:00 – 12:10 Objectives/Goals – Magdy Selim

  • 12:15 – 12:45 Current status of Surgery in ICH – East vs. West – Why are we at a standstill after MISTIE3, ENRICH and MIND?

  • 12:10 – 12:20 East – Xunming Ji 

  • 12:20 – 12:30 West – Fernanda Carvalho Poyraz 

  • 12:30 – 12:45 Ruben Dammers – Why are we at a standstill after MISTIE3, ENRICH and MIND?

12:45 – 14:45

15 min each


SESSION I – THE CONTROVERSIES AND UNKNOWNS
Moderators: Dan Hanley; Amal Abou-Hamden; Christopher Kellner; Jehuda Soleman; Kazunori Toyoda, Christophe Gaudin.

  • 12:45 – 13:00 Should there be a cut-off volume threshold to consider surgery? Is it location-dependent? – Andrea Morotti

  • 13:00 – 13:15 What is the optimal target post-evacuation hematoma volume? Is it location-dependent? – Wendy Ziai

  • 13:15 – 13:30 What is the optimal timing to perform surgery? Is it location-specific? – Karin Klijn

  • 13:30 – 13:45 Should the surgical approach/device vary based on ICH location? – Jay Mocco

  • 13:45 – 14:45 Discussion and emerging recommendations

14:45 – 15:15

Coffee Break/Lunch

15:15 – 17:00

15 min each


SESSION II – FUTURE FRONTIERS
Moderators: Jay Mocco; Joseph Broderick; Karin Klijn; Jesús Lafuente, Fernanda Carvalho Poyraz, Jerome Parcq.

  • 15:15 – 15.30 Emerging innovations and Robotics in ICH surgery – Christopher Kellner

  • 15:30 – 15:45 Surgery Plus: Is it time for multi-modal approaches? – Jehuda Soleman

  • 15:45 – 16:00 Could surgery be used to enhance recovery? – Amal Abou-Hamden

  • 16:00 – 16:45 Discussion and emerging recommendations

17:00 – 18:30

15 min each

Special session ISMINS guest society: Surgical management of Intracranial bleeding

Moderators: Francisco Gonzalez Llanos (SENEC President) & Shinichi Yoshimura

  • 17:00 – 17:15 Surgical management for hemorrhagic Moyamoya – Bin Xu

  • 17:15 – 17:30 Endoscopic aspiration of ICH through a burr hole: technique and devices – Alberto Feletti

  • 17:30 – 17:45 Endovascular and surgical approaches to large and giant cerebral aneurysms – Shinichi Yoshimura

  • 17:45 – 18.00 Minimally invasive management of hemorrhagic cavernomas – Ekkasrd Kasper

  • 18:00 – 18:15 Surgical management for acute ischemic stroke – Jorge Mura

  • 18:15 – 18:30 Management of hemorrhagic AVM – Nils Hecht

18:30 – 19:00

Coffee Break

19:00 – 20:15

15 min each

  • 19:00 – 19:15 How does AVM/Aneurysm related hemorrhage helps in deciding when to operate or embolize – Christoph Griessenauer

  • 19:15 – 19:30 Endoscopic Evacuation of Deep Intracerebral Haemorrhage versus Medical Treatment – Mao Yokota

  • 19:30 – 19:45 Advantages and pitfalls on the surgical treatment of SAH – Francisco Gonzalez Llanos

  • 19:45 – 20:00 Minimally invasive surgery for intracerebral hemorrhage in the emergency setting – Zhuoying Du

  • 20:00 – 20:15 Emergency neurosurgical hybrid operating room for acute intracranial hemorrhage – Pablo López Ojeda

08:30 – 08:45

Welcome and Opening Ceremony

Jesús Lafuente, David Rodríguez, Magdy Selim
08:45 – 10:25 15 min each 5 min abstract

Improving ICH Systems of Care

Moderators: Vasileios Lioutas & Pablo Villoslada
  • 08:45 – 09:00 Blood markers: GFAP and the DETECT study – Joan Montaner
  • 09:00 – 09:15 Ultra-early radiological diagnosis of ICH with portable devices – Adrian Parry-Jones
  • 09:15 – 09:30 Acute system of transfer: ambulance and mobile units for ICH – Lucia Picazo
  • 09:30 – 09:45 Direct Transfer of ICH to the Angiosuite – Rodriguez-Luna
  • 09:45 – 10:00 ICH care bundles and quality metrics – Teresa Ullberg
Oral Abstracts + Discussion:  
  • 10:00 – 10:05 Variation in Intracerebral Hemorrhage Care Beyond Patient Casemix: A Nationwide Registry Study – Gabriella Sultani
  • 10:05 – 10:10 Kalasin Hemorrhagic Stroke Education and Practice Improvement Programme – Supachai Srichantha
  • 10:10 – 10:15 Multiple Intracerebral Hemorrhage in emergency room: Incidence and Treatment of PUMCH experience – Yuanli Zha
10:25 – 10:45

Coffee Break

10:45 – 12:1015 min each 5 min abstract

Emergency Management

Moderators: Craig Anderson & Jesús Lafuente
  • 10:4511:00 Hematomal and perihematomal injury and repair after ICH – Laurent Puy
  • 11:0011:15 Reversal of Coagulopathy: INCH, ANNEXA-I, & RE-VERSE AD – What have we learned? What’s next? – Thorsten Steiner
  • 11:1511:30 Hemostatic Therapy: FASTEST, TICH3 and DASH2 – JP Broderick
  • 11:3011:45 Influence of time-to-achieve target systolic BP on outcome after ICH – Adnan QureshiOral Abstracts + Discussion: 
  • 11:45 – 11:50 Extreme dipping blood pressure pattern is associated with increased mortality in hemorrhagic stroke patients: a retrospective cohort study – Yan Jiang
  • 11:50 – 11:55 Achieved systolic blood pressure and recurrent vascular events after intracerebral hemorrhage – Xia Wang
  • 11:55 – 12:00 Tranexamic acid and desmopressin in intracerebral hemorrhage: multicentred randomised phase III trials (ISRCTN97695350) – Nikola Sprigg
  • 12:00 – 12:05 Thrombotic events, hematoma expansion and functional outcome: a secondary analysis of the TICH2 randomized controlled trial – Marta Garés
12:10 – 13:00

LUNCH (Courtesy of WICH)

12:30 – 13:00

Symposium by BAYER: “ADVANCES in STROKE: Factor XI Inhibition”

Moderator: Magdy Selim Invited Speakers: Ashkan Shoamanesh and Else Sandset
  • 12:10 – 12:30 Introductions/Objectives
  • 12:30 – 12:45 Factor XI Inhibition: Phase III data and lessons learned – Ashkan Shoamanesh.
  • 12:45 – 13:00 Risk of stroke and major adverse cardiovascular events in ICH survivors – Else Sandset
13:00 – 13:30

Expert Panel & Discussion (Open Questions & Future Research)

Drs. ShoamaneshSandset & Selim This would include data and considerations for FXIa inhibitors & hemorrhagic stroke
13:30 – 15:15

Interactive Session

Moderators: Kazunori Toyoda & Elisa Cuadrado
  • 13:30 – 13:45 Defining patient responder groups and prognostic algorithms – Andrea Morotti
  • 13:45 – 14:00 The use of vagus nerve stimulation in an animal model of ICH – Afshin Divani
  • 14:00 – 14:15 Past & future of neuroprotection against secondary injury after ICH – Magdy Selim
  • 14:15 – 14:30 Related and remote ischemic events in patients with ICH – Wendy Ziai
  • 14:30 – 14:45 Perihematomal edema & functional outcome after ICH: systematic review and meta-analysis – Floris Schreuder
  • 14:45 – 15:00 Use of MRI to map out white matter tracts within the hematoma – Neeraj Chaudhary
Oral Abstracts + Discussion:
  • 15:00 – 15:05 Systemic Cytokine Trajectories in Acute Intracerebral Hemorrhage: A Pilot Longitudinal Study – Fernanda Carvalho
  • 15:05 – 15:10 Association between Hematoma Clearance and Functional Outcome after Intracerebral Hemorrhage – Francesco Berinato
  • 15:10 – 15:15 Beyond ICP: Temporal Evolution of Cerebrovascular Autoregulation and Perfusion Targets in Severe Intracerebral Hemorrhage – Ana Ferreira
15:30 – 15:45

Coffee Break

15:45 – 17:45 15 min each 5 min abstract

Surgical Treatment (I)

Moderators: Xunming Ji & David Rodríguez
  • 15:45 – 16:00 Latest meta-analysis on minimally invasive surgery for ICH – David Rodriguez
  • 16:00 – 16:15 Rationale and future perspectives for the surgical treatment of ICH – Luís Ley
  • 16:15 – 16:30 Indications and optimal timing for minimally invasive surgery – Karin Klijn
  • 16:30 – 16:45 Appropriate ICH volume requiring evacuation and whether this varies based on ICH location – Marc Viles
  • 16:45 – 17:00 Overview of the modern minimally invasive evacuation techniques – Christopher Kellner
  • 17:00 – 17:15 The role of ultrasound in minimal invasive surgery for ICH – Aditya Pandey
Oral Abstracts + Discussion
  • 17:15 – 17:20 Rational Optimization of Sustained Thrombolysis for ICH Evacuation – Jérôme Parcq
  • 17:20 – 17:25 Timing and Hematoma Volume Metrics in Minimally Invasive Intracerebral Hemorrhage Evacuation: Location Specific Predictors from an ENRICH Post-Hoc Analysis – Leonardo Tariciotti
  • 17:25 – 17:30 Determinants of Surgical Performance During Minimally Invasive Intracerebral Hemorrhage Evacuation: An ENRICH Post-Hoc Analysis – Leonardo Tariciotti
17:45 – 18:55 5 min abstract

Rapid Fire Oral Abstracts

  • 17:45 – 17:50 Magnetization Transfer MRI Reveals Region and Time-Dependent Changes Following Experimental Intracerebral Hemorrhage – Gemma Manich
  • 17:50 – 17:55 Construction and Validation of Predictive Models for Long-term Prognosis of Patients with Primary Brainstem Hemorrhage Based on Machine Learning – Chuanyuan Tao
  • 17:55 – 18:00 Post stroke residual aphasia in stroke patients according to ischemic and hemorrhagic subytypes – Sahar Heidary
  • 18:00 – 18:05 Clinical, laboratory and neuroimaging predictors of outcome in spontaneous intracerebral hemorrhage – Oriol Barrachina Esteve
  • 18:05 – 18:10 Spatiotemporal Evolution of Molecular and Cellular Architecture Post-Intracerebral Hemorrhage in Aged Mice: A Spatial Transcriptomic and Mitochondrial Proteomic Study – Yi-Fan Liu
  • 18:10 – 18:15 A Phase I Dose-Escalation Study of Tenecteplase for Stereotactic Thrombolysis in Supratentorial Intracerebral Hemorrhage – Chao Pan
  • 18:15 – 18:20 Decreased lymphocyte-to-monocyte ratio is associated with poststroke depression in patients with spontaneous intracerebral hemorrhage at 3month – Lifei Lian
  • 18:20 – 18:25 Investigation and Analysis of Researchers’ Preferences in Participating Centers of the The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an International, Stepped Wedge Cluster Randomised Controlled Trial – Xi Li
  • 18:25 – 18:30 Current practices regarding seizure prophylaxis in aneurysmal subarachnoid hemorrhage in China – Yi Liu
  • 18:30 – 18:35 Intracranial Hemorrhage Secondary to Cerebral Venous Thrombosis: Two Cases with Identifiable Provoking Factors – HanLin Yen
  • Discussion
19:00 – 20:30

Welcome Reception (Courtesy of WICH)

08:30 – 10:10

15 min each
Abstr 5 min

Advancing clinical trials on the surgical management of ICH

Moderators: Christopher Kellner & Carlo Marras

  • 08:30 – 08:45 From ENRICH to REACH – Gustavo Pradilla

  • 08:45 – 09:00 From MIND to MINUTE – J Mocco

  • 09:00 – 09:15 EVACUATE – Amal Abou-Hamden

  • 09:15 – 09:30 EMINET – Jehuda Soleman

  • 09:30 – 09:45 DIST – Ruben Dammers

Oral Abstracts + Discussion

  • 09:45 – 09:50 Phase I safety of intravenous umbilical cord mesenchymal stem cells for subacute intracerebral hemorrhage – Na Liu

  • 09:50 – 09:55 DE-feroxamine inFUsion integrated with a-Spiration for the treatment of Intra-Cerebral Hemorrhage (DEFUSEICH): protocol for a multicenter randomized controlled trial – Xin Hu

10:10 – 10:30

Coffee Break

10:30 – 11:00

The Hoff Award – WICH General Assembly

Magdy Selim, Richard Keep & Dan Hanley

New Therapeutic & Molecular Targets in Hemorrhagic Stroke – Richard Keep

11:00 – 12:45

15 min each
Abstr 5 min

Interactive Session II

Moderators: Xia Wang & Esther Duarte

  • 11:00 – 11:15 Hydrocephalus, reebleeding, seizures and long-term surgical complications management – Ramón Navarro

  • 11:15 – 11:30 Mobilization and robotics in rehabilitation of ICH – Montse Bernabeu

  • 11:30 – 11:45 Cognition and Dementia after ICH – Mar Matarín

  • 11:45 – 12:00 Optima cerebral perfusion pressure measurement in ICH – Michel Torbey

  • 12:00 – 12:15 Non-invasive ICH monitoring: O3© and Sedline@ – Cristina Climent

 

Oral Abstracts + Discussion

 

  • 12:15 – 12:20 Postoperative volumetric distribution influence on recurrence of chronic subdural hematoma: A retrospective cohort study – Laurie Santerre

  • 12:20 – 12:25 Osmolality and hemorrhage burden for delayed cerebral ischemia risk evaluation post-aneurysm rupture – Edgaras Misiulis

  • 12:25 – 12:30 Functional Trajectories Between 90 Days and 1 Year After Intracerebral Hemorrhage: A Swedish Stroke Register Study – Marcus Johnsson

12:45 – 13:45

Lunch

13:45 – 15:55

15 min each
Abstr 5 min

Surgical Treatment II Germinal Matrix Hemorrhage and Intraventricular Therapies

Moderators: Ramón Navarro & José Hinojosa

  • 13:45 – 14:00 Minimally invasive surgery for IVH – Kristian Varga

  • 14:00 – 14:15 Advanced intraventricular therapies – Beatriz Fernández Muñoz

  • 14:15 – 14:30 Germinal matrix hemorrhage: pathophysiology and clinical spectrum – Ana Alarcón

  • 14:30 – 14:45 Outcomes of treatment with an Ommaya reservoir – Carlos Valencia

  • 14:45 – 15:00 Intraventricular lavage: how I do it – Javier Márquez

  • 15:00 – 15:15 Results of the TROPHY study: intraventricular lavage – Ulrich Thomale

  • 15:15 – 15:30 Prognosis and long-term outcomes – Thais Agut

 

Oral Abstracts + Discussion

 

  • 15:30 – 15:35 ASTIM TRIAL – Zhu Wei

  • 15:35 – 15:40 Characterization and fibrinolytic susceptibility of rivaroxaban associated intracerebral hematomas – Charlotte Bocquet

  • 15:40 – 15:45 Ventriculoperitoneal Shunt Demonstrates Superior Long-Term Outcomes Compared to Lumbo-peritoneal Shunt for Post-Hemorrhagic Hydrocephalus: A Multicenter Cohort Study – Tong Sun

  • 15:45 – 15:50 Myeloid LAMP2A deficiency inhibits hematoma clearance following intracerebral hemorrhage – Mei Fang

  • 15:50 – 15:55 Mechanism of βHydroxybutyrate in Promoting Angiogenesis and Reducing Secondary Brain Injury Following Intracerebral Hemorrhage via Activation of Crebbp-Mediated Histone Acetylation Reprogramming – Rui Tian

15:55 – 16:10

Coffee Break

16:10 – 17:15

Prevention & Challenging Decision-Making

Moderators: Lili Song & Thomaz Topzcewski

  • 16:10 – 16:25 When OAC cannot be restarted after ICH: The role of left atrial appendage occlusion in AF – Ashkan Shoamanesh

  • 16:25 – 16:40 How many pills do we need for BP control after ICH? The TRIDENT Trial – Craig Anderson

  • 16:40 – 16:55 Antiplatelet and anticoagulant treatment after ICH: A systematic review of the guidelines – David Seiffge

 

Oral Abstracts + Discussion

 

  • 16:55 – 17:00 Persistent Gaps in Secondary Prevention After First Ever Intracranial Hemorrhage in Primary Care: Sex Differences from a Chilean Real World Retrospective Cohort (2016–2024) – Marilaura Nuñez

  • 17:00 – 17:05 Tracking ICH Survivors in Southern Denmark: Cohort Design and Long-Term Outcomes – Camilla Renée Olofsson Storm

17:15 – 17:45

Closing Ceremony and Group Photo

Jesús Lafuente, Xunming Ji & Magdy Selim